127 related articles for article (PubMed ID: 20213202)
21. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
23. Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?
Horisberger K; Hofheinz RD; Palma P; Volkert AK; Rothenhoefer S; Wenz F; Hochhaus A; Post S; Willeke F
Int J Colorectal Dis; 2008 Mar; 23(3):257-64. PubMed ID: 18071720
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
25. Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers.
Delaney CP; Lavery IC; Brenner A; Hammel J; Senagore AJ; Noone RB; Fazio VW
Ann Surg; 2002 Aug; 236(2):203-7. PubMed ID: 12170025
[TBL] [Abstract][Full Text] [Related]
26. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting anastomotic complications following anterior resection in rectal cancer.
Lyall A; Mc Adam TK; Townend J; Loudon MA
Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
[TBL] [Abstract][Full Text] [Related]
28. [A comparative study in rectal adenocarcinoma: preoperative or postoperative radiotherapy].
Martín de Vidales C; Cerezo L; Vázquez de la Torre ML; Zapatero A; Del Cerro E; Pinar B; Domínguez P; Pérez Torrubia A
Rev Esp Enferm Dig; 1995 Mar; 87(3):199-204. PubMed ID: 7742048
[TBL] [Abstract][Full Text] [Related]
29. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party.
Lancet; 1996 Dec; 348(9042):1605-10. PubMed ID: 8961989
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
Zhang Q; Tey J; Yang Z; Li P; Peng L; Jiang R; Xiong F; Fu S; Lu JJ
Am J Clin Oncol; 2014 Feb; 37(1):8-12. PubMed ID: 22892433
[TBL] [Abstract][Full Text] [Related]
31. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
32. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
33. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
[TBL] [Abstract][Full Text] [Related]
34. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
35. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
[TBL] [Abstract][Full Text] [Related]
36. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
Créhange G; Bosset JF; Maingon P
Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
[TBL] [Abstract][Full Text] [Related]
37. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.
Kim CJ; Yeatman TJ; Coppola D; Trotti A; Williams B; Barthel JS; Dinwoodie W; Karl RC; Marcet J
Ann Surg; 2001 Sep; 234(3):352-8; discussion 358-9. PubMed ID: 11524588
[TBL] [Abstract][Full Text] [Related]
38. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
Hughes R; Harrison M; Glynne-Jones R
Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
[TBL] [Abstract][Full Text] [Related]
39. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
